Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib is effective and safe for treating alopecia areata.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Baricitinib works better than methotrexate for severe alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Clotrimazole, an antifungal cream, may safely reduce skin pigmentation by breaking down the enzyme needed for making melanin.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Erbium-YAG laser treatment improved folliculitis decalvans without causing hair loss.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Topical cyclosporine lotion led to noticeable hair regrowth in alopecia universalis.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.